Home › Funds › UNIVEST FINANCIAL Corp › VRTX

UNIVEST FINANCIAL Corp position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

UNIVEST FINANCIAL Corp reported holding 21,785 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.53% of its reported portfolio and ranking #40 among its reported holdings. UNIVEST FINANCIAL Corp has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)21.79K sh
Reported value held$11.39M
Portfolio Weight0.53%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How UNIVEST FINANCIAL Corp's VRTX position evolved

UNIVEST FINANCIAL Corp first disclosed a stake in VRTX in Q1 2025 at 3,890 shares (US$1.9M). The position peaked in Q3 2026 at 21,785 shares, worth US$11.4M. Across 7 filings, UNIVEST FINANCIAL Corp increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 21,785 shares valued at US$11.4M — an increase of 12,736 shares quarter over quarter.. Notable position changes include a 54% increase in Q2 2025 (shares fell 12% over the following quarter), a 28% increase in Q2 2026 (shares rose 5% over the following quarter), a 141% increase in Q3 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.89K $1.89M New
Q2 2025 5.98K $2.66M Add
Q3 2025 7.36K $2.88M Add
Q4 2025 6.10K $2.76M Reduce
Q1 2026 7.06K $3.15M Add
Q2 2026 9.05K $4.49M Add
Q3 2026 21.79K $11.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has UNIVEST FINANCIAL Corp held VRTX?

UNIVEST FINANCIAL Corp has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is UNIVEST FINANCIAL Corp's current position in VRTX?

As of Q3 2026, UNIVEST FINANCIAL Corp holds 21.79K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $11.39M, representing 0.53% of its reported portfolio and ranking #40.

Has UNIVEST FINANCIAL Corp been buying or selling VRTX?

In the latest 13F filing (Q3 2026), UNIVEST FINANCIAL Corp increased its position in VRTX. The position peaked in Q3 2026 at 21.79K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.